FindTrial
Sign In

The tumors biological treatment of non-surgical hepatocellular carcinoma

The tumors biological treatment of non-surgical hepatocellular carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONRC-12002722
Enrollment
Unknown
Registered
2012-11-24
Start date
2012-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inoperable hepatocellular carcinoma

Interventions

group 6:Traditional chemotherapy+Bevacizumab+CIK+Megestrol
group 1:Traditional chemotherapy
Group 2:Traditional chemotherapy+Bevacizumab
group 3:Traditional chemotherapy+CIK
group 4:chemotherapy+Bevacizumab+CIK
group 5:Traditional chemotherapy+Megestrol

Sponsors

First Affiliated Hospital, Shenzhen University, Futian District, Shenzhen, Guangdong Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. both male and female; 2. Diagnosed with liver cancer, inoperable; 3. informed consent, ability to understand the study information.

Exclusion criteria

Exclusion criteria: patient refused

Design outcomes

Primary

MeasureTime frame
AFP;CT;Survival time;—

Countries

China

Contacts

Public ContactTian Geng
tiangeng666@yahoo.com.cn+86 13724395569

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026